Know what
goes in.

A small 16-week study in adults with mild cognitive impairment used about 2.9 g of mushroom powder daily, a different dose and preparation from Clarimind. A 2025 acute study found no benefit for global cognition or mood.

Several trials assessed standardized extracts over 12 weeks. Clarimind matches the nominal 300 mg and 50% amounts in one older trial, but this does not establish an identical extract. A 2025 trial found no benefit on primary cognitive outcomes.

The trial used branded Cognizin in women aged 40–60. Clarimind lists citicoline, which does not establish that the same branded ingredient or identical results apply. The study used one-tailed statistical tests.

A 28-day study used 576 mg/day of SHR-5 in people with stress-related fatigue. A different trial in nursing students favored placebo for fatigue. Neither tested Clarimind’s 250 mg, 5% salidrosides preparation.

A 200 mg acute trial studied short-term laboratory stress. A four-week 200 mg study found some sleep-component improvements, but not a consistent advantage on overall stress or cognition. This does not establish all-day calm or a guaranteed immediate effect.